Derisking Psychiatric Drug Development The NIMH's Fast Fail Program, A Novel Precompetitive Model

被引：17
|
作者：
Grabb, Margaret C. [1 ]
Cross, Alan J. [2 ]
Potter, William Z. [1 ]
McCracken, James T. [3 ]
机构：
[1] NIMH, NIH, 6001 Execut Blvd,Room 7203,MSC 9645, Rockville, MD 20852 USA
[2] AstraZeneca Neurosci Innovat Med Unit, Cambridge, MA USA
[3] UCLA Semel Inst Neurosci, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 05期
关键词：
NERVOUS-SYSTEM; AUTISM; PHARMACOLOGY; DISORDERS;
D O I：
10.1097/JCP.0000000000000536
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：419 / 421
页数：3
相关论文
共 50 条
  • [41] Development of the Dutch Johne's disease control program supported by a simulation model
    Groenendaal, H
    Nielen, M
    Hesselink, JW
    PREVENTIVE VETERINARY MEDICINE, 2003, 60 (01) : 69 - 90
  • [42] Development and results of a novel pancreas transplant program in Spain: the surgeon's point of view
    Munoz-Bellvis, Luis
    del Carmen Esteban, Maria
    Iglesias, Manuel
    Gonzalez, Luis
    Ignacio Gonzalez-Munoz, Juan
    Munoz-Gonzalez, Cristina
    Quinones, Jose E.
    Tabernero, Guadalupe
    Ana Iglesias, Rosa
    Maria Sayagues, Jose
    Fraile, Pilar
    CIRUGIA ESPANOLA, 2018, 96 (04): : 205 - 212
  • [43] A novel fast-slow model of diabetes progression: Insights into mechanisms of response to the interventions in the Diabetes Prevention Program
    De Gaetano, Andrea
    Hardy, Thomas Andrew
    PLOS ONE, 2019, 14 (10):
  • [44] Development of A Novel Renal Organoid Model Using Whole Kidney Cells for Drug Screening
    Chen, L.
    Bai, Y.
    Zeng, X.
    Jackson, J.
    Atala, A.
    TISSUE ENGINEERING PART A, 2016, 22 : S65 - S66
  • [45] Is the pharmaceutical industry’s preoccupation with the monotherapy drug model stifling the development of effective new drug therapies?
    Ian Edwin Cock
    Inflammopharmacology, 2018, 26 : 861 - 879
  • [46] Is the pharmaceutical industry's preoccupation with the monotherapy drug model stifling the development of effective new drug therapies?
    Cock, Ian Edwin
    INFLAMMOPHARMACOLOGY, 2018, 26 (03) : 861 - 879
  • [47] DEVELOPMENT OF A NOVEL EMPIRICAL MODEL TO ESTIMATE THE KRAFT PULP YIELD OF FAST-GROWING EUCALYPTUS
    Liu, Jing
    Hu, Huichao
    Luo, Xiaolin
    BIORESOURCES, 2012, 7 (01): : 1134 - 1144
  • [48] Formulation Development and Evaluation of Fast Disintegrating Tablets of Ambroxol Hydrochloride for Pediatrics-A Novel Approach for Drug Delivery
    Sharma, Deepak
    Singh, Mankaran
    Kumar, Dinesh
    Singh, Gurmeet
    Rathore, Mahendra Singh
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2014, 48 (04) : 40 - 48
  • [49] What is the gold standard model for Alzheimer's disease drug discovery and development?
    Cacabelos, Ramon
    Carrera, Ivan
    Martinez-Iglesias, Olaia
    Cacabelos, Natalia
    Naidoo, Vinogran
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (12) : 1415 - 1440
  • [50] A safety monitoring procedure for a clinical drug development program, with application to the assessment of a novel COX-2 inhibitor
    Bolland, Kim
    Whitehead, John
    Oldham, Mary
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2008, 18 (04) : 737 - 749
12345